Menu Search
Equities

Compumedics Ltd

CMP:ASX

Compumedics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.285
  • Today's Change-0.005 / -1.72%
  • Shares traded2.00k
  • 1 Year change+46.15%
  • Beta1.8346
Data delayed at least 20 minutes, as of Nov 17 2024 23:02 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Compumedics Ltd grew revenues 17.24% from 42.41m to 49.72m while net income improved from a loss of 6.12m to a smaller loss of 338.00k.
Gross margin52.43%
Net profit margin-0.68%
Operating margin2.81%
Return on assets-0.83%
Return on equity-1.85%
Return on investment-1.73%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Compumedics Ltd fell by 2.57m. However, the company earned 2.00m from its operations for a Cash Flow Margin of 4.02%. In addition the company used 2.99m on investing activities and also paid 1.49m in financing cash flows.
Cash flow per share0.0077
Price/Cash flow per share43.26
Book value per share0.1028
Tangible book value per share0.0454
More ▼

Balance sheet in AUDView more

Compumedics Ltd has a Debt to Total Capital ratio of 32.02%, a higher figure than the previous year's 8.53%.
Current ratio1.23
Quick ratio0.6131
Total debt/total equity0.4711
Total debt/total capital0.3202
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.